Stryker (SYK) Tops Q1 EPS by 4c, Boosts FY Gudiance

Go back to Stryker (SYK) Tops Q1 EPS by 4c, Boosts FY Gudiance

Stryker (SYK) PT, Estimates Raised at Piper Jaffray Following Solid Q1

April 21, 2016 8:43 AM EDT

Piper Jaffray analyst Matt O'Brien reiterated an Overweight rating and raised his price target on Stryker (NYSE: SYK) to $120.00 (from $110.00) following solid Q1 results.

O'Brien commented, "This evening, Stryker reported Q1 results that beat on both the top and bottom line and... More

Leerink Partners Raises Price Target on Stryker (SYK) to $125 Following 1Q Results

April 21, 2016 7:53 AM EDT

Leerink Partners reiterated an Outperform rating on Stryker (NYSE: SYK), and raised the price target to $125.00 (from $111.00), following the company's 1Q Results. Revenue growth of +6.1% organic was ~100bps above consensus thinking, as the Neuro/Spine division outperformed due to growth in the ischemic stroke market.... More